Ronnett B M, Shmookler B M, Diener-West M, Sugarbaker P H, Kurman R J
Department of Pathology, Johns Hopkins Hospital, Baltimore, Maryland, USA.
Int J Gynecol Pathol. 1997 Jan;16(1):1-9. doi: 10.1097/00004347-199701000-00001.
Women with pseudomyxoma peritonei (PMP), characterized by multifocal mucinous implants (disseminated peritoneal adenomucinosis), often have synchronous appendiceal and ovarian mucinous tumors. There has been considerable debate as to whether the ovarian tumors are secondary to the appendiceal tumor or are independent primary ovarian tumors; the latter are usually classified as mucinous tumors of low malignant potential (MLMP). It has been reported that cytokeratins (CK) 7, 18, and 20, carcinoembryonic antigen (CEA), and human alveolar macrophage 56 (HAM-56) are useful markers for distinguishing primary ovarian neoplasms from metastases of intestinal origin. Nearly all primary ovarian MLMP tumors and mucinous carcinomas are positive for CK 7, 18, and 20, CEA, and HAM-56, whereas most colorectal adenocarcinomas are negative for both CK 7 and HAM-56 and positive for CK 20 and CEA. Thirteen appendiceal and 14 ovarian mucinous tumors from 14 cases of PMP and 11 primary ovarian MLMP tumors were studied immunohistochemically for expression of CK 7, 18, and 20, monoclonal and polyclonal CEA (mCEA and pCEA), and HAM-56. Of 14 cases of PMP, 10 (71.4%) had identical staining patterns for all antibodies in both the appendiceal and ovarian tumors. For eight of these, the pattern of immunoreactivity was characterized by negative reactions for CK 7 and HAM-56 and positive reactions for CK 18 and 20, mCEA, and pCEA. One additional case for which only the ovarian tumor could be stained had the same pattern. The remaining two cases were also positive for CK 18 and 20 and CEA, but in addition were positive for CK 7. Two cases were discordant only for CK 7 and one case was discordant for both CK 7 and HAM-56. All 11 MLMP tumors were positive for CK 7 and 18, and pCEA. Eight (72.7%) of 11 were positive for HAM-56, mCEA, and CK 20. There was a statistically significant difference in the frequency of immunoreactivity for CK 7 (p = 0.0005) and HAM-56 (p = 0.0002) between the ovarian mucinous tumors in PMP and the MLMP tumors, with the ovarian tumors in PMP tending to be negative for CK 7 and HAM-56, similar to the appendiceal adenomas. Most ovarian mucinous tumors in PMP demonstrate a pattern of immunoreactivity with CK 7, 18, and 20, CEA, and HAM-56 that is identical to the associated appendiceal adenoma and distinct from primary ovarian MLMP tumors, consistent with the interpretation that these ovarian tumors are secondary to the appendiceal tumor.
腹膜假黏液瘤(PMP)女性患者的特征为多灶性黏液性植入物(播散性腹膜腺黏液瘤病),常伴有同步性阑尾和卵巢黏液性肿瘤。关于卵巢肿瘤是继发于阑尾肿瘤还是独立的原发性卵巢肿瘤,一直存在相当大的争议;后者通常归类为低恶性潜能黏液性肿瘤(MLMP)。据报道,细胞角蛋白(CK)7、18和20、癌胚抗原(CEA)以及人肺泡巨噬细胞56(HAM - 56)是区分原发性卵巢肿瘤与肠道源性转移瘤的有用标志物。几乎所有原发性卵巢MLMP肿瘤和黏液腺癌CK 7、18和20、CEA以及HAM - 56均呈阳性,而大多数结直肠癌腺癌CK 7和HAM - 56均为阴性,CK 20和CEA为阳性。对14例PMP患者的13个阑尾黏液性肿瘤和14个卵巢黏液性肿瘤以及11个原发性卵巢MLMP肿瘤进行免疫组化研究,以检测CK 7、18和20、单克隆和多克隆CEA(mCEA和pCEA)以及HAM - 56的表达。在14例PMP患者中,10例(71.4%)阑尾和卵巢肿瘤中所有抗体的染色模式相同。其中8例的免疫反应模式表现为CK 7和HAM - 56呈阴性反应,CK 18和20、mCEA和pCEA呈阳性反应。另外1例仅卵巢肿瘤可染色的病例也具有相同模式。其余2例CK 18和20以及CEA也呈阳性,但此外CK 7也呈阳性。2例仅在CK 7方面不一致,1例在CK 7和HAM - 56两方面均不一致。所有11个MLMP肿瘤CK 7和18以及pCEA均呈阳性。11个中有8个(72.7%)HAM - 56、mCEA和CK 20呈阳性。PMP中的卵巢黏液性肿瘤与MLMP肿瘤在CK 7(p = 0.0005)和HAM - 56(p = 0.0002)免疫反应频率上存在统计学显著差异,PMP中的卵巢肿瘤CK 7和HAM - 56往往呈阴性,与阑尾腺瘤相似。PMP中大多数卵巢黏液性肿瘤的免疫反应模式与相关阑尾腺瘤相同,与原发性卵巢MLMP肿瘤不同,这与这些卵巢肿瘤继发于阑尾肿瘤的解释一致。